Skip to main content

Advertisement

SpringerLink
Log in

Effect of resistance training on pathological cardiac hypertrophy and FGF23-Klotho axis-induced adverse cardiovascular outcomes in rats with CKD

  • Original Article
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

  • 1 Altmetric

Abstract

Patients with chronic kidney disease (CKD) confront with cardiovascular disease (CVD) complications which can be ameliorated with exercise. The purpose of the current study was to determine the effect of resistance training on pathological cardiac hypertrophy and FGF23-Klotho axis-induced adverse cardiovascular outcomes in rat model of CKD. Thirty male Wistar rats (7–8 weeks old) were randomly divided into three groups of the 5/6 nephrectomy (5/6NX) with and without resistance training and control group. The resistance training protocol consisted of 3 sessions per week. The proposed blood factors (Klotho, FGF23, serum phosphorus, parathyroid hormone, serum calcium, and vitamin D) evaluated for three groups at the end of 8th week. After confirming the normal distribution of data through Kolmogorov–Smirnov test, data analysis was performed by one-way ANOVA and Bonferroni post hoc test (P > 0.05). The effect of resistance training was significantly different between 3 groups of study for hypertrophy (P = 0.036) and cardiac function (P = 0.004). There was also a significant difference for blood factors of Klotho (P = 0.000), FGF23 (P = 0.043), serum phosphorus (P = 0.00), and parathyroid (P = 0.00). Serum calcium (P = 0.06) and vitamin D status (P = 0.06) improved but the differences were not significant. Resistance training can prevent progression of pathological cardiac hypertrophy in patients with renal disease. In the process of this improvement, changes in FGF23 and Klotho were significant; however, the vitamin D and calcium have played a less important role.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Alexander RT et al (2009) Klotho prevents renal calcium loss. J Am Soc Nephrol 20(11):2371–2379

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ali BH et al (2014) Does swimming exercise affect experimental chronic kidney disease in rats treated with gum acacia? PLoS ONE 9(7):e102528

    Article  PubMed  PubMed Central  Google Scholar 

  • Balakrishnan VS et al (2010) Resistance training increases muscle mitochondrial biogenesis in patients with chronic kidney disease. Clin J Am Soc Nephrol 5(6):996–1002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ben-Dov IZ et al (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Investig 117(12):4003–4008

    CAS  PubMed  PubMed Central  Google Scholar 

  • Castaneda C et al (2004) Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. Am J Kidney Dis 43(4):607–616

    Article  PubMed  Google Scholar 

  • Cozzolino M et al (2017) The cardiovascular burden in end-stage renal disease. Expanded Hemodialysis 191:44–57

    Google Scholar 

  • Desjardins L et al (2012) FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int 23(7):2017–2025

    Article  CAS  PubMed  Google Scholar 

  • Dussold C et al (2019) DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease. Bone Res 7(1):1–12

    Article  CAS  Google Scholar 

  • Faul C et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Investig 121(11)

  • Greenwood SA et al (2015) Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial. Am J Kidney Dis 65(3):425–434

    Article  PubMed  Google Scholar 

  • Gutierrez O et al (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16(7):2205–2215

    Article  CAS  PubMed  Google Scholar 

  • Hasegawa H et al (2010) Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int 78(10):975–980

    Article  CAS  PubMed  Google Scholar 

  • Heiwe S et al (2005) Effects of regular resistance training on muscle histopathology and morphometry in elderly patients with chronic kidney disease. Am J Phys Med Rehabil 84(11):865–874

    Article  PubMed  Google Scholar 

  • Hu MC et al (2017) Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. Kidney Int 91(5):1104–1114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Huang C-L (2010) Regulation of ion channels by secreted Klotho: mechanisms and implications. Kidney Int 77(10):855–860

    Article  PubMed  Google Scholar 

  • Keshavarzi Z et al (2017) The effect of 12 weeks of aerobic exercise on plasma levels of fibroblast growth factor 23, angiotensin converting enzyme and left ventricular hypertrophy in hypertensive elderly women. SSU_J;25(3):222–229

  • Komaba H, Fukagawa M (2010) FGF23–parathyroid interaction: implications in chronic kidney disease. Kidney Int 77(4):292–298

    Article  CAS  PubMed  Google Scholar 

  • Lavi-Moshayoff V et al (2010) PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol 299(4):F882–F889

    Article  CAS  PubMed  Google Scholar 

  • Levey AS, Coresh J (2012) Chronic kidney disease. Lancet 379(9811):165–180

    Article  PubMed  Google Scholar 

  • Maltese G, Karalliedde J (2012) The putative role of the antiageing protein klotho in cardiovascular and renal disease. Int J Hypertens 2012

  • Metzinger-Le Meuth V et al (2017) microRNAs in the pathophysiology of CKD-MBD: biomarkers and innovative drugs. Biochim Biophys Acta (BBA) Mol Basis Dis (1):337–345

  • Moe SM et al (2009) A rat model of chronic kidney disease-mineral bone disorder. Kidney Int 75(2):176–184

    Article  CAS  PubMed  Google Scholar 

  • Moinuddin I, Leehey DJ (2008) A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Adv Chronic Kidney Dis 15(1):83–96

    Article  PubMed  Google Scholar 

  • Naranjo M, Lerma EV, Rangaswami J (2017) Cardio-renal syndrome: a double edged sword. Dis-a-Mon: DM 63(4):92–100

  • Palazzuoli A et al (2014) Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin. Heart Fail Rev 19(2):267–284

    Article  CAS  PubMed  Google Scholar 

  • Paoli S, Mitsnefes MM (2014) Coronary artery calcification and cardiovascular disease in children with chronic kidney disease. Curr Opin Pediatr 26(2):193

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pavik I et al (2013) Secreted Klotho and FGF23 in chronic kidney disease stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant 28(2):352–359

    Article  CAS  PubMed  Google Scholar 

  • Pechter Ü et al (2003) Beneficial effects of water-based exercise in patients with chronic kidney disease. Int J Rehabil Res 26(2):153–156

    PubMed  Google Scholar 

  • Ramez M et al (2019) The greater effect of high-intensity interval training versus moderate-intensity continuous training on cardioprotection against ischemia-reperfusion injury through Klotho levels and attenuate of myocardial TRPC6 expression. BMC Cardiovasc Disord 19(1):1–10

    Article  CAS  Google Scholar 

  • Rossaint J et al (2016) FGF23 signaling impairs neutrophil recruitment and host defense during CKD. J Clin Investig 126(3):962–974

    Article  PubMed  PubMed Central  Google Scholar 

  • Sahn DJ et al (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58(6):1072–1083

  • Takeshita K et al (2004) Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 109(14):1776–1782

    Article  PubMed  Google Scholar 

  • Tan RZ et al (2019) An optimized 5/6 nephrectomy mouse model based on unilateral kidney ligation and its application in renal fibrosis research. Ren Fail 41(1):555–566

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tucker PS, Scanlan AT, Dalbo VJ (2015) High intensity interval training favourably affects angiotensinogen mRNA expression and markers of cardiorenal health in a rat model of early-stage chronic kidney disease. BioMed Res Int 2015

  • Wahl P, Wolf M (2012) FGF23 in chronic kidney disease. Endocrine FGFs and Klothos p. 107–125

  • Yamazaki Y et al (2010) Establishment of sandwich ELISA for soluble alpha-Klotho measurement: age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun 398(3):513–518

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang H-C, Zuo Y, Fogo AB (2010) Models of chronic kidney disease. Drug Discov Today Dis Model 7(1–2):13–19

    Article  CAS  Google Scholar 

  • Yoshida T, Fujimori T, Nabeshima Y-I (2002) Mediation of unusually high concentrations of 1, 25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1α-hydroxylase gene. Endocrinology 143(2):683–689

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are thankful to the Tehran University of Medical Sciences (TUMS), Iran, for providing necessary research facilities.

Author information

Authors and Affiliations

  1. Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, University of Tehran, Tehran, Iran

    Zahra Shahsavari, Rahman Soori & Sina Rokhsati

  2. Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Shahram Rabbani & Safieh Boroumand

  3. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Safieh Boroumand

Authors
  1. Zahra Shahsavari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rahman Soori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shahram Rabbani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Safieh Boroumand
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sina Rokhsati
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zahra Shahsavari.

Ethics declarations

Funding

This study was not supported by any funding.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

For this type of study informed consent is not required.

Consent for publication

For this type of study consent for publication is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shahsavari, Z., Soori, R., Rabbani, S. et al. Effect of resistance training on pathological cardiac hypertrophy and FGF23-Klotho axis-induced adverse cardiovascular outcomes in rats with CKD. Comp Clin Pathol 32, 519–526 (2023). https://doi.org/10.1007/s00580-023-03455-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-023-03455-4

Keywords

Search

Navigation